SCHEMBL3610149

SCHEMBL3610149

O=S(=O)(c1cccnc1)n1ccc2c(Br)cccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 13/20 0.51
▸ MET P08581 4/20 0.45
▸ DRD2 P14416 3/20 0.45
▸ HTR2A P28223 2/20 0.45
▸ PPARG P37231 1/20 0.44
▸ PPARD Q03181 1/20 0.44
▸ PPARA Q07869 1/20 0.44
▸ HTR1A P08908 3/20 0.43
▸ HTR1D P28221 2/20 0.43
▸ HTR1B P28222 2/20 0.43
▸ HTR1F P30939 2/20 0.43
▸ HTR7 P34969 2/20 0.43
▸ DRD3 P35462 2/20 0.43
▸ HDAC3 O15379 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC7 Q8WUI4 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC10 Q969S8 1/20 0.41
▸ HDAC11 Q96DB2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL260867 0.83 HTR6 (0.68) HTR6METDRD2HTR2AHTR1A
SCHEMBL30644286 0.83 HTR6 (0.68) HTR6METDRD2HTR2AHTR1A
SCHEMBL3624929 0.82 HTR6 (0.49) HTR6METDRD2HTR2AHTR1A
SCHEMBL3623408 0.81 HTR6 (0.48) HTR6METDRD2HTR2AHTR1A
SCHEMBL13504563 0.80 HTR6 (0.47) HTR6METDRD2HTR2AHTR1A
SCHEMBL3623035 0.78 HTR6 (0.58) HTR6DRD2HTR1AHTR1DHTR1B
SCHEMBL505125 0.76 HTR6 (0.56) HTR6DRD2HTR2APPARGPPARD
SCHEMBL30096985 0.76 HTR6 (0.56) HTR6DRD2HTR2APPARGPPARD
SCHEMBL3618873 0.76 HTR6 (0.61) HTR6DRD2HTR1AHTR1DHTR1B
SCHEMBL4306121 0.76 HTR6 (0.75) HTR6DRD2HTR2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046741-B1 INDOLES AS 5-HT6 MODULATORS PROXIMAGEN LTD (GB) 2012-10-31 — — EP disclosed
US-7812017-B2 4-substituted indole and indoline compounds BIOVITRUM AB (PUBL.) (SE) 2010-10-12 — — US disclosed
EP-2046741-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (publ) (SE) 2009-04-15 — — EP disclosed
US-20080032968-A1 New compounds PROXIMAGEN NEUROSCIENCE PLC (GB) 2008-02-07 — — US disclosed
WO-2008003703-A1 INDOLES AS 5-HT6 MODULATORS BIOVITRUM AB (PUBL) (SE) 2008-01-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080032968-A1 New compounds HTR6, HTR1B, HTR1A HTR6 1/4885MET 853/4885DRD2 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback